|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
|
|---|---|---|---|---|---|
| Assets | |||||
| Current assets | |||||
| Cash | |||||
| Prepaid expenses | |||||
| Total current assets | |||||
| Deferred offering costs | |||||
| Investments held in Trust Account | |||||
| Total Assets | |||||
| Current liabilities | |||||
| Due to related party | |||||
| Accounts payable | |||||
| Accounts payable and accrued expenses | |||||
| Promissory notes - related party | |||||
| Total current liabilities | |||||
| Deferred underwriting fee payable | |||||
| Total Liabilities | |||||
| Commitments and Contingencies (Note 6) | |||||
| Class A ordinary shares, $0.0001 par value; 450,000,000 shares authorized; 5,750,000 shares subject to possible redemption | |||||
| Shareholders’ (Deficit) Equity: | |||||
| Ordinary shares, value | |||||
| Class A Ordinary Shares | |||||
| Class B ordinary shares | |||||
| Additional paid-in capital | |||||
| Accumulated deficit | |||||
| Total shareholders’ (deficit) equity | |||||
| Total Liabilities, Ordinary Shares Subject to Redemption and Shareholders’ (Deficit) Equity |
Loading...